Clinical trial

MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant

NCT00283738 · NMT Medical, Industry · Unknown status

Key facts

NCT number NCT00283738
Title MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant
Official title A Prospective, Multi-Center, Double-Blinded, Placebo-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With the BioSTAR Septal Repair Implant to Reduce Refractory Migraine Headache With Aura.
Lead sponsor NMT Medical, Industry
Status Unknown status
Phase Phase 2/Phase 3
Study type Interventional
Conditions Migraine, Aura, Patent Foramen Ovale
Intervention type Device, Procedure
Interventions BioSTAR Septal Repair Implant System, Sham Procedure
Enrollment 610
Start date Feb 1, 2006
Completion Mar 1, 2008
First posted Jan 30, 2006
Last update posted Jan 25, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies